Actavis Acquires Botox Maker Allergan Pharmaceuticals

Actavis Acquires Botox Maker Allergan Pharmaceuticals

November 19, 2014
By Beverly Brooks
The Plastic Surgery Channel

Some changes are in the works for Botox® maker Allergan. Botox, the gold standard for non surgical removal of frown lines, will now be run by pharmaceutical giant Actavis, in what’s perceived as a positive move by many board certified plastic surgeons.

wp2“Despite market trends and shareholder demands, Allergan has remained focused on research and development,” says Caroline Glicksman, MD, a board certified plastic surgeon in New Jersey. “It is my sincere hope that their commitment to our patients through medical innovation continues after the acquisition by Actavis.”

Allergan Dodges Hostile Takeover by Valeant

Allergan dodged a hostile takeover by another pharma company Valeant Pharmaceuticals, Inc., with a recent offer valued at $54 billion.

Hundreds of letters from the medical community expressed concern about Valeant Pharmaceuticals.  The disagreement revolved around fears that Valeant would sharply cut Allergan’s funding in research-and-development.

“Research, development, and clinical education have always been very important for Allergan, which is why the Valeant hostile bid was disconcerting,” says Pat McGuire, MD, a board certified plastic surgeon in St. Louis.

SONY DSCWill Actavis Support Botox® and Research?

“Actavis seems to have a similar philosophy to Allergan, with a strong commitment to research and development, so this appears to be a positive merger,” says Dr. Pat McGuire.

“I work for an innovative company — that’s why I’m working for Allergan,” says Philippe Schaison, President of U.S. Medical for Allergan, “I’m all about science, and we have the duty to bring innovation to patients and physicians.”

While Botox is a game changer when it comes to eliminating frown lines, Allergan has also captured a huge market share with the recent introduction of JUVÉDERM VOLUMA® XC to the United States. Voluma is the first and only FDA-approved injectable gel to instantly add volume to the cheek area and give the face a subtle lift for up to two years.

Allergan also recently launched SERI Surgical Scaffold, a bio-degradable material used in procedures requiring tissue support in the breast and abdomen.

The recent acquisition is perceived as a win-win in many medical circles because it positions Actavis as a top ten global pharmaceutical company, with more than a dozen medical advances already in the ‘pipeline’ or development stage.

Click to add a comment

More in

In-Office Lipo: Too Good to be True?

John HammarleyAugust 3, 2021
Breast Implant Illness - Still A Concern? Are There Any Updates?

Breast Implant Illness – Still A Concern? Are There Any Updates?

Jason Pozner, MDJuly 28, 2021
Artificial Intelligence and the Future of Plastic Surgery

Artificial Intelligence and the Future of Plastic Surgery

Patricia McGuire, MDJuly 21, 2021
Can you say Goodbye to Aging for Good with Prejuvenation?

Can We Say Goodbye to Aging for Good with Prejuvenation?

Dawn TongishJuly 15, 2021

Look-Live Surgery Breast Augmentation and Mastopexy

M. Bradley Calobrace, MDJuly 13, 2021

90 Day Fiancé Star Refuses to Quit Smoking Before Surgery

Jason Pozner, MDJuly 12, 2021
When is the Best Time to Start Laser Treatments?

When is the Best Time to Start Laser Treatments?

Jason Pozner, MDJuly 7, 2021
The Breast Implant Checklist for Patients

The Breast Implant Checklist for Patients

William P. Adams, Jr., MDJune 30, 2021
The Best Bang for Your Buck to Rejuvenate the Face

The Best Bang for Your Buck to Rejuvenate the Face

Dustin Reid, MDJune 24, 2021